ARDX
ARDELYX, INC.
- Latest sale
- $6k
- Aug 21 · No plan
- Form 4 sales
- 326
- On record
- Form 144 notices
- 14
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleNo planAug 21 2026
Sold 19,750 shares at $3.86 ($76k)
Bishop John E, Officer
No 10b5-1 planSold 5.9% of holdings ($1.3M position)317,095 shares leftFiling
- 2 Form 4 saleNo planAug 21 same day
Sold 58,574 shares at $3.86 ($226k)
Raab Michael, President & CEO
No 10b5-1 planSold 3.5% of holdings ($6.5M position)1.6M shares left1.4x usual sizeFiling
- 3 Form 4 saleNo planAug 21 same day
Sold 10,739 shares at $3.86 ($41k)
Williams Laura A, Chief Patient Officer
No 10b5-1 planSold 2.8% of holdings ($1.5M position)367,456 shares left1.5x usual sizeFiling
- 4 Form 4 saleNo planAug 21 same day
Sold 7,758 shares at $3.86 ($30k)
Kelliher Mike, Chief Business Officer
No 10b5-1 planSold 2.2% of holdings ($1.4M position)349,660 shares left1.1x usual sizeFiling
- 5 Form 4 saleNo planAug 21 same day
Sold 8,562 shares at $3.86 ($33k)
Foster Eric Duane, Chief Commercial Officer
No 10b5-1 planSold 2% of holdings ($1.6M position)409,410 shares left1.1x usual sizeFiling
- 6 Form 4 saleNo planAug 21 same day
Sold 3,982 shares at $3.86 ($15k)
Reilly Joseph James, Officer
No 10b5-1 planSold 2.7% of holdings ($578k position)145,854 shares left0.8x usual sizeFiling
- 7 Form 4 saleNo planAug 21 same day
Sold 15,136 shares at $3.86 ($58k)
Brady James Parker, Chief Human Resources Officer
No 10b5-1 planSold 5.8% of holdings ($1M position)245,930 shares leftFiling
- 8 Form 4 saleNo planAug 21 same day
Sold 1,558 shares at $3.86 ($6k)
Hohenleitner Susan, Chief Financial Officer
No 10b5-1 planSold 0.7% of holdings ($884k position)227,520 shares leftFiling
Every transaction
Loading transactions…
Sales, notices and lockups (340)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Aug 21, 2026 | Hohenleitner Susan | Chief Financial Officer | Form 4 sale | 1,558 | $6k | 0.7% | No plan | SEC |
| Aug 21, 2026 | Brady James Parker | Chief Human Resources Officer | Form 4 sale | 15,136 | $58k | 5.8% | No plan | SEC |
| Aug 21, 2026 | Reilly Joseph James | Officer | Form 4 sale | 3,982 | $15k | 2.7% | No plan | SEC |
| Aug 21, 2026 | Foster Eric Duane | Chief Commercial Officer | Form 4 sale | 8,562 | $33k | 2.0% | No plan | SEC |
| Aug 21, 2026 | Kelliher Mike | Chief Business Officer | Form 4 sale | 7,758 | $30k | 2.2% | No plan | SEC |
| Aug 21, 2026 | Williams Laura A | Chief Patient Officer | Form 4 sale | 10,739 | $41k | 2.8% | No plan | SEC |
| Aug 21, 2026 | Raab Michael | President & CEO | Form 4 sale | 58,574 | $226k | 3.5% | No plan | SEC |
| Aug 21, 2026 | Bishop John E | Officer | Form 4 sale | 19,750 | $76k | 5.9% | No plan | SEC |
| Jul 15, 2026 | Raab Michael | President & CEO | Form 4 sale | 41,668 | $211k | 2.4% | Routine | SEC |
| Jun 18, 2026 | Williams Laura A | Chief Patient Officer | Form 4 sale | 81,898 | $491k | 17.8% | Unusual | SEC |
| Jun 15, 2026 | Raab Michael | President & CEO | Form 4 sale | 41,666 | $236k | 2.4% | Routine | SEC |
| May 21, 2026 | Hohenleitner Susan | Chief Financial Officer | Form 4 sale | 1,455 | $9k | 0.6% | No plan | SEC |
| May 21, 2026 | Brady James Parker | Chief Human Resources Officer | Form 4 sale | 1,846 | $12k | 0.7% | No plan | SEC |
| May 21, 2026 | Reilly Joseph James | Officer | Form 4 sale | 3,719 | $23k | 2.4% | No plan | SEC |
| May 21, 2026 | Foster Eric Duane | Chief Commercial Officer | Form 4 sale | 7,998 | $50k | 1.9% | No plan | SEC |
| May 21, 2026 | Kelliher Mike | Chief Business Officer | Form 4 sale | 7,248 | $45k | 2.0% | No plan | SEC |
| May 21, 2026 | Williams Laura A | Chief Patient Officer | Form 4 sale | 6,989 | $44k | 1.6% | No plan | SEC |
| May 21, 2026 | Raab Michael | President & CEO | Form 4 sale | 54,748 | $343k | 3.1% | No plan | SEC |
| May 21, 2026 | Bishop John E | Officer | Form 4 sale | 2,306 | $14k | 0.7% | No plan | SEC |
| May 15, 2026 | Raab Michael | President & CEO | Form 4 sale | 41,666 | $262k | 2.3% | Routine | SEC |
| Apr 15, 2026 | Raab Michael | President & CEO | Form 4 sale | 41,668 | $262k | 2.3% | Routine | SEC |
| Mar 16, 2026 | Raab Michael | President & CEO | Form 4 sale | 41,666 | $243k | 2.2% | Routine | SEC |
| Feb 24, 2026 | Raab Michael | President & CEO | Form 4 sale | 41,666 | $261k | 2.2% | Routine | SEC |
| Feb 20, 2026 | Bishop John E | Officer | Form 4 sale | 3,179 | $19k | 0.9% | No plan | SEC |
| Feb 20, 2026 | Reilly Joseph James | Officer | Form 4 sale | 4,991 | $29k | 3.2% | No plan | SEC |
| Feb 20, 2026 | Williams Laura A | Officer | Form 4 sale | 8,176 | $48k | 1.8% | No plan | SEC |
| Feb 20, 2026 | Hohenleitner Susan | Chief Financial Officer | Form 4 sale | 2,033 | $12k | 0.9% | No plan | SEC |
| Feb 20, 2026 | Brady James Parker | Chief Human Resources Officer | Form 4 sale | 2,543 | $15k | 1.0% | No plan | SEC |
| Feb 20, 2026 | Kelliher Mike | Officer | Form 4 sale | 9,595 | $56k | 2.6% | No plan | SEC |
| Feb 20, 2026 | Raab Michael | President & CEO | Form 4 sale | 45,982 | $269k | 2.4% | No plan | SEC |
| Feb 20, 2026 | Foster Eric Duane | Chief Commercial Officer | Form 4 sale | 10,439 | $61k | 2.4% | No plan | SEC |
| Jan 8, 2026 | Williams Laura A | Chief Patient Officer | Form 4 sale | 50,000 | $349k | 12.1% | Unusual | SEC |
| Nov 21, 2025 | Grammer Elizabeth A | Officer | Form 4 sale | 5,995 | $33k | 2.0% | No plan | SEC |
| Nov 21, 2025 | Raab Michael | President & CEO | Form 4 sale | 46,887 | $260k | 3.1% | No plan | SEC |
| Nov 21, 2025 | Kelliher Mike | Officer | Form 4 sale | 5,560 | $31k | 2.0% | No plan | SEC |
| Nov 21, 2025 | Williams Laura A | Chief Patient Officer | Form 4 sale | 6,426 | $36k | 1.8% | No plan | SEC |
| Nov 21, 2025 | Foster Eric Duane | Chief Commercial Officer | Form 4 sale | 5,814 | $32k | 1.9% | No plan | SEC |
| Nov 21, 2025 | Reilly Joseph James | Officer | Form 4 sale | 11,086 | $61k | 9.2% | No plan | SEC |
| Aug 26, 2025 | Williams Laura A | Chief Patient Officer | Form 4 sale | 80,000 | $490k | 17.9% | Unusual | SEC |
| Aug 21, 2025 | Kelliher Mike | Chief Business Officer | Form 4 sale | 5,417 | $32k | 1.9% | No plan | SEC |
| Aug 21, 2025 | Williams Laura A | Chief Patient Officer | Form 4 sale | 6,261 | $37k | 1.6% | No plan | SEC |
| Aug 21, 2025 | Renz Justin A | Chief Financial Officer | Form 4 sale | 7,037 | $42k | 1.7% | No plan | SEC |
| Aug 21, 2025 | Raab Michael | President & CEO | Form 4 sale | 45,687 | $271k | 3.0% | No plan | SEC |
| Aug 21, 2025 | Grammer Elizabeth A | Officer | Form 4 sale | 5,841 | $35k | 1.9% | No plan | SEC |
| Aug 21, 2025 | Foster Eric Duane | Chief Commercial Officer | Form 4 sale | 15,308 | $91k | 4.8% | No plan | SEC |
| May 20, 2025 | Williams Laura A | Chief Medical Officer | Form 4 sale | 6,421 | $26k | 1.6% | No plan | SEC |
| May 20, 2025 | Renz Justin A | Chief Financial Officer | Form 4 sale | 7,218 | $29k | 1.7% | No plan | SEC |
| May 20, 2025 | Raab Michael | President & CEO | Form 4 sale | 46,817 | $191k | 2.9% | No plan | SEC |
| May 20, 2025 | Kelliher Mike | Officer | Form 4 sale | 14,522 | $59k | 4.9% | No plan | SEC |
| May 20, 2025 | Grammer Elizabeth A | Officer | Form 4 sale | 5,992 | $24k | 1.9% | No plan | SEC |
| May 20, 2025 | Foster Eric Duane | Chief Commercial Officer | Form 4 sale | 2,507 | $10k | 0.8% | No plan | SEC |
| May 2, 2025 | Raab Michael | President & CEO | Form 4 sale | 41,666 | $177k | 2.5% | Routine | SEC |
| Apr 4, 2025 | Raab Michael | President & CEO | Form 4 sale | 41,666 | $191k | 2.5% | Routine | SEC |
| Mar 7, 2025 | Raab Michael | President & CEO | Form 4 sale | 41,668 | $223k | 2.5% | Routine | SEC |
| Feb 20, 2025 | Williams Laura A | Chief Medical Officer | Form 4 sale | 4,941 | $28k | 1.6% | No plan | SEC |
| Feb 20, 2025 | Renz Justin A | Chief Financial Officer | Form 4 sale | 5,171 | $29k | 1.8% | No plan | SEC |
| Feb 20, 2025 | Raab Michael | President & CEO | Form 4 sale | 22,964 | $129k | 2.1% | No plan | SEC |
| Feb 20, 2025 | Grammer Elizabeth A | Officer | Form 4 sale | 4,291 | $24k | 2.3% | No plan | SEC |
| Jan 31, 2025 | Raab Michael | President & CEO | Form 4 sale | 41,666 | $223k | 3.6% | Unusual | SEC |
| Jan 7, 2025 | Raab Michael | President & CEO | Form 4 sale | 41,666 | $221k | 3.6% | Unusual | SEC |
| Dec 10, 2024 | Raab Michael | President & CEO | Form 4 sale | 25,000 | $132k | 2.1% | Routine | SEC |
| Dec 10, 2024 | Raab Michael | Officer, Director | Form 144 notice | 25,000 | $132k | Notice | SEC | |
| Nov 25, 2024 | Raab Michael | President & CEO | Form 4 sale | 25,000 | $134k | 2.1% | Routine | SEC |
| Nov 25, 2024 | Raab Michael | Officer, Director | Form 144 notice | 25,000 | $134k | Notice | SEC | |
| Nov 20, 2024 | Williams Laura A | Chief Medical Officer | Form 4 sale | 7,366 | $35k | 2.3% | No plan | SEC |
| Nov 20, 2024 | Rosenbaum David P. | Chief Development Officer | Form 4 sale | 7,184 | $34k | 2.4% | No plan | SEC |
| Nov 20, 2024 | Renz Justin A | Chief Financial Officer | Form 4 sale | 5,260 | $25k | 1.8% | No plan | SEC |
| Nov 20, 2024 | Raab Michael | President & CEO | Form 4 sale | 31,980 | $153k | 2.6% | Unusual | SEC |
| Nov 20, 2024 | Grammer Elizabeth A | Officer | Form 4 sale | 7,046 | $34k | 3.7% | No plan | SEC |
| Nov 20, 2024 | Blanks Robert | Officer | Form 4 sale | 4,941 | $24k | 1.5% | No plan | SEC |
| Nov 11, 2024 | Raab Michael | President & CEO | Form 4 sale | 2,743 | $13k | 0.2% | Routine | SEC |
| Nov 6, 2024 | Rosenbaum David P. | Chief Development Officer | Form 4 sale | 27,171 | $166k | 15.0% | Unusual | SEC |
| Nov 4, 2024 | Rosenbaum David P. | Chief Development Officer | Form 4 sale | 27,172 | $162k | 15.0% | Unusual | SEC |
| Oct 28, 2024 | Raab Michael | President & CEO | Form 4 sale | 25,000 | $148k | 2.0% | Routine | SEC |
| Oct 11, 2024 | Raab Michael | President & CEO | Form 4 sale | 7,500 | $45k | 0.6% | Routine | SEC |
| Sep 27, 2024 | Rosenbaum David P. | Chief Development Officer | Form 4 sale | 49,564 | $343k | 14.1% | Unusual | SEC |
| Sep 26, 2024 | Raab Michael | President & CEO | Form 4 sale | 3,000 | $18k | 0.2% | Routine | SEC |
| Sep 13, 2024 | Rosenbaum David P. | Chief Development Officer | Form 4 sale | 5,312 | $33k | 3.3% | No plan | SEC |
| Sep 11, 2024 | Raab Michael | President & CEO | Form 4 sale | 35,000 | $196k | 2.8% | Unusual | SEC |
| Aug 27, 2024 | Raab Michael | President & CEO | Form 4 sale | 7,500 | $47k | 0.6% | Routine | SEC |
| Aug 20, 2024 | Williams Laura A | Chief Medical Officer | Form 4 sale | 7,412 | $43k | 2.3% | No plan | SEC |
| Aug 20, 2024 | Rosenbaum David P. | Chief Development Officer | Form 4 sale | 7,219 | $42k | 2.0% | No plan | SEC |
| Aug 20, 2024 | Renz Justin A | Chief Financial Officer | Form 4 sale | 5,289 | $31k | 1.8% | No plan | SEC |
| Aug 20, 2024 | Raab Michael | President & CEO | Form 4 sale | 32,225 | $189k | 2.6% | Unusual | SEC |
| Aug 20, 2024 | Grammer Elizabeth A | Officer | Form 4 sale | 7,089 | $42k | 3.6% | No plan | SEC |
| Aug 20, 2024 | Felsch Robert Ora | Officer | Form 4 sale | 3,567 | $21k | 3.7% | No plan | SEC |
| Aug 20, 2024 | Blanks Robert | Officer | Form 4 sale | 4,969 | $29k | 1.5% | No plan | SEC |
| Aug 20, 2024 | Rosenbaum David P. | Chief Development Officer | Form 4 sale | 40,507 | $242k | 10.2% | Unusual | SEC |
| Aug 12, 2024 | Raab Michael | President & CEO | Form 4 sale | 1,229 | $7k | 0.1% | Routine | SEC |
| Jul 29, 2024 | Raab Michael | President & CEO | Form 4 sale | 30,000 | $169k | 2.3% | Unusual | SEC |
| Jul 15, 2024 | Raab Michael | President & CEO | Form 4 sale | 7,500 | $45k | 0.6% | Routine | SEC |
| Jun 28, 2024 | Raab Michael | President & CEO | Form 4 sale | 2,310 | $15k | 0.2% | Routine | SEC |
| Jun 21, 2024 | Blanks Robert | Officer | Form 4 sale | 38,000 | $226k | 10.5% | Unusual | SEC |
| Jun 13, 2024 | Raab Michael | President & CEO | Form 4 sale | 35,000 | $233k | 2.7% | Unusual | SEC |
| Jun 5, 2024 | Williams Laura A | Chief Medical Officer | Form 4 sale | 145,000 | $1M | 31.0% | Unusual | SEC |
| Jun 3, 2024 | Rosenbaum David P. | Chief Development Officer | Form 4 sale | 17,872 | $125k | 10.1% | Unusual | SEC |
| May 29, 2024 | Raab Michael | President & CEO | Form 4 sale | 7,500 | $50k | 0.6% | Routine | SEC |
| May 21, 2024 | Williams Laura A | Chief Medical Officer | Form 4 sale | 4,794 | $37k | 1.3% | No plan | SEC |
| May 21, 2024 | Rosenbaum David P. | Chief Development Officer | Form 4 sale | 7,053 | $55k | 1.8% | No plan | SEC |
| May 21, 2024 | Rodriguez Susan | Chief Commercial Officer | Form 4 sale | 6,703 | $52k | 1.5% | No plan | SEC |
| May 21, 2024 | Renz Justin A | Chief Financial Officer | Form 4 sale | 5,167 | $40k | 1.7% | No plan | SEC |
| May 21, 2024 | Raab Michael | President & CEO | Form 4 sale | 31,484 | $246k | 2.4% | No plan | SEC |
| May 21, 2024 | Grammer Elizabeth A | Officer | Form 4 sale | 6,927 | $54k | 3.4% | No plan | SEC |
| May 21, 2024 | Felsch Robert Ora | Officer | Form 4 sale | 3,485 | $27k | 3.5% | No plan | SEC |
| May 21, 2024 | Blanks Robert | Officer | Form 4 sale | 4,855 | $38k | 1.3% | No plan | SEC |
| May 14, 2024 | Raab Michael | President & CEO | Form 4 sale | 3,000 | $24k | 0.2% | Routine | SEC |
| May 6, 2024 | Felsch Robert Ora | Officer | Form 4 sale | 207,988 | $1.8M | 68.4% | Unusual | SEC |
| May 6, 2024 | Grammer Elizabeth A | Officer | Form 4 sale | 284,170 | $2.5M | 58.2% | Unusual | SEC |
| May 3, 2024 | Grammer Elizabeth A | Officer | Form 4 sale | 45,000 | $405k | 14.4% | Unusual | SEC |
| May 3, 2024 | Williams Laura A | Chief Medical Officer | Form 4 sale | 39,949 | $334k | 9.7% | Unusual | SEC |
| Apr 29, 2024 | Raab Michael | President & CEO | Form 4 sale | 30,000 | $192k | 2.2% | Routine | SEC |
| Apr 15, 2024 | Raab Michael | President & CEO | Form 4 sale | 7,500 | $53k | 0.6% | Routine | SEC |
| Apr 1, 2024 | Raab Michael | President & CEO | Form 4 sale | 1,518 | $11k | 0.1% | Routine | SEC |
| Mar 20, 2024 | Grammer Elizabeth A | Officer | Form 4 sale | 86,000 | $665k | 21.6% | Unusual | SEC |
| Feb 26, 2024 | Rosenbaum David P. | Chief Development Officer | Form 4 sale | 5,183 | $48k | 2.9% | No plan | SEC |
| Feb 20, 2024 | Rosenbaum David P. | Chief Development Officer | Form 4 sale | 7,311 | $64k | 1.9% | No plan | SEC |
| Feb 20, 2024 | Renz Justin A | Chief Financial Officer | Form 4 sale | 5,341 | $47k | 1.7% | No plan | SEC |
| Feb 20, 2024 | Raab Michael | President & CEO | Form 4 sale | 22,917 | $201k | 1.7% | No plan | SEC |
| Feb 20, 2024 | Blanks Robert | Officer | Form 4 sale | 5,017 | $44k | 1.3% | No plan | SEC |
| Feb 20, 2024 | Grammer Elizabeth A | Officer | Form 4 sale | 4,432 | $39k | 1.1% | No plan | SEC |
| Feb 20, 2024 | Rodriguez Susan | Chief Commercial Officer | Form 4 sale | 6,928 | $61k | 1.5% | No plan | SEC |
| Feb 20, 2024 | Felsch Robert Ora | Officer | Form 4 sale | 2,352 | $21k | 1.3% | No plan | SEC |
| Feb 20, 2024 | Williams Laura A | Chief Medical Officer | Form 4 sale | 4,803 | $42k | 1.2% | No plan | SEC |
| Feb 8, 2024 | Rosenbaum David P. | Chief Development Officer | Form 4 sale | 15,344 | $141k | 3.8% | Unusual | SEC |
| Jan 8, 2024 | Rosenbaum David P. | Chief Development Officer | Form 4 sale | 30,000 | $199k | 9.5% | Unusual | SEC |
| Dec 26, 2023 | Renz Justin A | Chief Financial Officer | Form 4 sale | 225,000 | $1.4M | 55.2% | Unusual | SEC |
| Dec 26, 2023 | Renz Justin A | Officer | Form 144 notice | 225,000 | $1.4M | Notice | SEC | |
| Dec 18, 2023 | Rosenbaum David P. | Chief Development Officer | Form 4 sale | 5,675 | $34k | 1.8% | Routine | SEC |
| Dec 18, 2023 | Rosenbaum David P. | Officer | Form 144 notice | 5,675 | $34k | Notice | SEC | |
| Dec 14, 2023 | Rosenbaum David P. | Chief Development Officer | Form 4 sale | 7,000 | $39k | 2.1% | Routine | SEC |
| Dec 14, 2023 | Rosenbaum David P. | Officer | Form 144 notice | 7,000 | $39k | Notice | SEC | |
| Dec 11, 2023 | Grammer Elizabeth A | Officer | Form 4 sale | 50,000 | $254k | 15.4% | Unusual | SEC |
| Dec 11, 2023 | Grammer Elizabeth A | Officer | Form 144 notice | 50,000 | $254k | Notice | SEC | |
| Dec 8, 2023 | Rosenbaum David P. | Officer | Form 144 notice | 20,000 | $105k | Notice | SEC | |
| Dec 8, 2023 | Rosenbaum David P. | Chief Development Officer | Form 4 sale | 20,000 | $105k | 5.7% | Unusual | SEC |
| Dec 5, 2023 | Rosenbaum David P. | Chief Development Officer | Form 4 sale | 10,272 | $51k | 2.9% | Unusual | SEC |
| Dec 5, 2023 | Rosenbaum David P. | Officer | Form 144 notice | 10,272 | $51k | Notice | SEC | |
| Nov 30, 2023 | Rosenbaum David P. | Chief Development Officer | Form 4 sale | 3,000 | $14k | 0.8% | Routine | SEC |
| Nov 30, 2023 | Rosenbaum David P. | Officer | Form 144 notice | 3,000 | $14k | Notice | SEC | |
| Nov 20, 2023 | Williams Laura A | Chief Medical Officer | Form 4 sale | 2,581 | $11k | 1.0% | No plan | SEC |
| Nov 20, 2023 | Rosenbaum David P. | Chief Development Officer | Form 4 sale | 3,767 | $16k | 1.0% | No plan | SEC |
| Nov 20, 2023 | Rodriguez Susan | Chief Commercial Officer | Form 4 sale | 4,714 | $21k | 1.3% | No plan | SEC |
| Nov 20, 2023 | Renz Justin A | Chief Financial Officer | Form 4 sale | 2,873 | $13k | 0.9% | No plan | SEC |
| Nov 20, 2023 | Raab Michael | President & CEO | Form 4 sale | 11,368 | $50k | 1.3% | No plan | SEC |
| Nov 20, 2023 | Grammer Elizabeth A | Officer | Form 4 sale | 2,384 | $10k | 0.7% | No plan | SEC |
| Nov 20, 2023 | Felsch Robert Ora | Officer | Form 4 sale | 1,044 | $5k | 0.9% | No plan | SEC |
| Nov 20, 2023 | Blanks Robert | Officer | Form 4 sale | 2,835 | $12k | 1.1% | No plan | SEC |
| Nov 15, 2023 | Williams Laura A | Chief Medical Officer | Form 4 sale | 25,000 | $100k | 8.6% | Unusual | SEC |
| Nov 15, 2023 | Williams Laura A | Officer | Form 144 notice | 25,000 | $102k | Notice | SEC | |
| Oct 10, 2023 | Rosenbaum David P. | Chief Development Officer | Form 4 sale | 1,644 | $7k | 0.4% | Routine | SEC |
| Oct 10, 2023 | Rosenbaum David P. | Officer | Form 144 notice | 1,644 | $7k | Notice | SEC | |
| Sep 8, 2023 | Rosenbaum David P. | Chief Development Officer | Form 4 sale | 2,897 | $13k | 0.8% | Routine | SEC |
| Sep 8, 2023 | Rosenbaum David P. | Officer | Form 144 notice | 2,897 | $13k | Notice | SEC | |
| Aug 21, 2023 | Rodriguez Susan | Chief Commercial Officer | Form 4 sale | 4,733 | $17k | 1.3% | No plan | SEC |
| Aug 21, 2023 | Williams Laura A | Chief Medical Officer | Form 4 sale | 2,591 | $9k | 0.9% | No plan | SEC |
| Aug 21, 2023 | Rosenbaum David P. | Chief Development Officer | Form 4 sale | 3,783 | $13k | 1.0% | No plan | SEC |
| Aug 21, 2023 | Renz Justin A | Chief Financial Officer | Form 4 sale | 2,884 | $10k | 0.9% | No plan | SEC |
| Aug 21, 2023 | Raab Michael | President & CEO | Form 4 sale | 11,419 | $41k | 1.3% | No plan | SEC |
| Aug 21, 2023 | Grammer Elizabeth A | Officer | Form 4 sale | 2,392 | $8k | 0.7% | No plan | SEC |
| Aug 21, 2023 | Felsch Robert Ora | Officer | Form 4 sale | 1,048 | $4k | 0.9% | No plan | SEC |
| Aug 21, 2023 | Blanks Robert | Officer | Form 4 sale | 2,846 | $10k | 1.1% | No plan | SEC |
| Jun 27, 2023 | Williams Laura A | Chief Medical Officer | Form 4 sale | 25,000 | $84k | 7.8% | Unusual | SEC |
| Jun 27, 2023 | Williams Laura A | Officer | Form 144 notice | 25,000 | $84k | Notice | SEC | |
| Jun 23, 2023 | Blanks Robert | Officer | Form 4 sale | 33,333 | $121k | 11.1% | Unusual | SEC |
| Jun 23, 2023 | Blanks Robert | Officer | Form 144 notice | 33,333 | $121k | Notice | SEC | |
| May 23, 2023 | Felsch Robert Ora | Officer | Form 4 sale | 1,046 | $4k | 0.9% | No plan | SEC |
| May 23, 2023 | Raab Michael | President & CEO | Form 4 sale | 11,357 | $41k | 1.3% | No plan | SEC |
| May 23, 2023 | Grammer Elizabeth A | Officer | Form 4 sale | 2,384 | $9k | 0.7% | No plan | SEC |
| May 23, 2023 | Blanks Robert | Officer | Form 4 sale | 2,835 | $10k | 1.1% | No plan | SEC |
| May 23, 2023 | Renz Justin A | Chief Financial Officer | Form 4 sale | 2,873 | $10k | 0.8% | No plan | SEC |
| May 23, 2023 | Rodriguez Susan | Chief Commercial Officer | Form 4 sale | 4,711 | $17k | 1.3% | No plan | SEC |
| May 23, 2023 | Rosenbaum David P. | Chief Development Officer | Form 4 sale | 3,769 | $14k | 1.0% | No plan | SEC |
| May 23, 2023 | Williams Laura A | Chief Medical Officer | Form 4 sale | 2,583 | $9k | 0.8% | No plan | SEC |
| Mar 29, 2023 | Rosenbaum David P. | Chief Development Officer | Form 4 sale | 3,000 | $14k | 2.6% | No plan | SEC |
| Feb 21, 2023 | Rodriguez Susan | Chief Commercial Officer | Form 4 sale | 5,586 | $17k | 1.5% | Plan not stated | SEC |
| Feb 21, 2023 | Williams Laura A | Chief Medical Officer | Form 4 sale | 3,187 | $10k | 1.0% | Plan not stated | SEC |
| Feb 21, 2023 | Blanks Robert | Officer | Form 4 sale | 3,394 | $10k | 1.2% | Plan not stated | SEC |
| Feb 21, 2023 | Grammer Elizabeth A | Officer | Form 4 sale | 2,914 | $9k | 0.9% | Plan not stated | SEC |
| Feb 21, 2023 | Raab Michael | President & CEO | Form 4 sale | 13,449 | $40k | 1.5% | Plan not stated | SEC |
| Feb 21, 2023 | Felsch Robert Ora | Officer | Form 4 sale | 3,214 | $10k | 2.7% | Plan not stated | SEC |
| Feb 21, 2023 | Renz Justin A | Chief Financial Officer | Form 4 sale | 3,439 | $10k | 1.0% | Plan not stated | SEC |
| Feb 21, 2023 | Rosenbaum David P. | Chief Development Officer | Form 4 sale | 4,508 | $14k | 1.2% | Plan not stated | SEC |
| Nov 22, 2022 | Rosenbaum David P. | Chief Development Officer | Form 4 sale | 1,948 | $4k | 0.6% | Plan not stated | SEC |
| Nov 22, 2022 | Grammer Elizabeth A | Officer | Form 4 sale | 1,242 | $2k | 0.5% | Plan not stated | SEC |
| Nov 22, 2022 | Rodriguez Susan | Chief Commercial Officer | Form 4 sale | 3,456 | $7k | 1.2% | Plan not stated | SEC |
| Nov 22, 2022 | Raab Michael | President & CEO | Form 4 sale | 6,219 | $12k | 0.9% | Plan not stated | SEC |
| Nov 22, 2022 | Renz Justin A | Chief Financial Officer | Form 4 sale | 1,504 | $3k | 0.6% | Plan not stated | SEC |
| Nov 22, 2022 | Williams Laura A | Chief Medical Officer | Form 4 sale | 1,241 | $2k | 0.5% | Plan not stated | SEC |
| Nov 22, 2022 | Blanks Robert | Officer | Form 4 sale | 1,464 | $3k | 0.7% | Plan not stated | SEC |
| Oct 5, 2022 | Blanks Robert | Officer | Form 4 sale | 100,000 | $150k | 33.8% | Unusual | SEC |
| Sep 1, 2022 | Rosenbaum David P. | Chief Development Officer | Form 4 sale | 3,000 | $3k | 3.2% | Plan not stated | SEC |
| Aug 26, 2022 | Blanks Robert | Officer | Form 4 sale | 21,842 | $23k | 6.9% | Unusual | SEC |
| Aug 22, 2022 | Rodriguez Susan | Chief Commercial Officer | Form 4 sale | 3,420 | $3k | 1.2% | Plan not stated | SEC |
| Aug 22, 2022 | Rosenbaum David P. | Chief Development Officer | Form 4 sale | 1,955 | $2k | 0.6% | Plan not stated | SEC |
| Aug 22, 2022 | Blanks Robert | Officer | Form 4 sale | 1,458 | $1k | 0.5% | Plan not stated | SEC |
| Aug 22, 2022 | Raab Michael | President & CEO | Form 4 sale | 6,146 | $6k | 0.9% | Plan not stated | SEC |
| Aug 22, 2022 | Grammer Elizabeth A | Officer | Form 4 sale | 1,236 | $1k | 0.5% | Plan not stated | SEC |
| Aug 22, 2022 | Williams Laura A | Chief Medical Officer | Form 4 sale | 1,276 | $1k | 0.5% | Plan not stated | SEC |
| Aug 22, 2022 | Renz Justin A | Chief Financial Officer | Form 4 sale | 1,498 | $1k | 0.6% | Plan not stated | SEC |
| Jul 26, 2022 | Blanks Robert | Officer | Form 4 sale | 5,188 | $3k | 1.6% | Unusual | SEC |
| Jun 6, 2022 | Renz Justin A | Chief Financial Officer | Form 4 sale | 73,312 | $48k | 21.9% | Unusual | SEC |
| Jun 6, 2022 | Rodriguez Susan | Chief Commercial Officer | Form 4 sale | 43,920 | $29k | 13.2% | Unusual | SEC |
| Jun 6, 2022 | Blanks Robert | Officer | Form 4 sale | 73,312 | $48k | 18.4% | Unusual | SEC |
| Jun 6, 2022 | Grammer Elizabeth A | Officer | Form 4 sale | 60,821 | $40k | 19.3% | Unusual | SEC |
| Jun 6, 2022 | Rosenbaum David P. | Chief Development Officer | Form 4 sale | 61,640 | $40k | 16.9% | Unusual | SEC |
| Jun 6, 2022 | Raab Michael | President & CEO | Form 4 sale | 103,624 | $67k | 13.4% | Unusual | SEC |
| May 20, 2022 | Rosenbaum David P. | Chief Development Officer | Form 4 sale | 2,013 | $1k | 0.6% | Plan not stated | SEC |
| May 20, 2022 | Renz Justin A | Chief Financial Officer | Form 4 sale | 1,528 | $1k | 0.5% | Plan not stated | SEC |
| May 20, 2022 | Rodriguez Susan | Chief Commercial Officer | Form 4 sale | 3,425 | $2k | 1.0% | Unusual | SEC |
| May 20, 2022 | Blanks Robert | Officer | Form 4 sale | 1,489 | $998 | 0.4% | Plan not stated | SEC |
| May 20, 2022 | Raab Michael | President & CEO | Form 4 sale | 6,124 | $4k | 0.8% | Plan not stated | SEC |
| May 20, 2022 | Grammer Elizabeth A | Officer | Form 4 sale | 1,263 | $846 | 0.4% | Plan not stated | SEC |
| Feb 22, 2022 | Renz Justin A | Chief Financial Officer | Form 4 sale | 1,800 | $1k | 0.5% | Plan not stated | SEC |
| Feb 22, 2022 | Blanks Robert | Officer | Form 4 sale | 1,752 | $1k | 0.4% | Plan not stated | SEC |
| Feb 22, 2022 | Raab Michael | President & CEO | Form 4 sale | 6,229 | $4k | 0.8% | Plan not stated | SEC |
| Feb 22, 2022 | Grammer Elizabeth A | Officer | Form 4 sale | 1,528 | $1k | 0.5% | Plan not stated | SEC |
| Feb 22, 2022 | Rosenbaum David P. | Chief Development Officer | Form 4 sale | 2,353 | $2k | 0.7% | Plan not stated | SEC |
| Feb 22, 2022 | Rodriguez Susan | Chief Commercial Officer | Form 4 sale | 3,400 | $2k | 1.0% | Unusual | SEC |
| Dec 15, 2021 | Sandell Scott D | 10% owner | Form 4 sale | 2.9M | $3.6M | 56.1% | Unusual | SEC |
| Dec 15, 2021 | Baskett Forest | 10% owner | Form 4 sale | 2.9M | $3.6M | 56.1% | Unusual | SEC |
| Nov 22, 2021 | Rosenbaum David P. | Chief Development Officer | Form 4 sale | 827 | $819 | 0.3% | Plan not stated | SEC |
| Nov 22, 2021 | Rodriguez Susan | Chief Commercial Officer | Form 4 sale | 643 | $637 | 0.3% | Plan not stated | SEC |
| Nov 22, 2021 | Renz Justin A | Chief Financial Officer | Form 4 sale | 643 | $637 | 0.2% | Plan not stated | SEC |
| Nov 22, 2021 | Raab Michael | President & CEO | Form 4 sale | 2,607 | $3k | 0.4% | Plan not stated | SEC |
| Nov 22, 2021 | Jacobs Jeffrey W | Chief Scientific Officer | Form 4 sale | 5,754 | $6k | 4.6% | Plan not stated | SEC |
| Nov 22, 2021 | Blanks Robert | Officer | Form 4 sale | 643 | $637 | 0.2% | Plan not stated | SEC |
| Nov 22, 2021 | Grammer Elizabeth A | Officer | Form 4 sale | 537 | $532 | 0.2% | Plan not stated | SEC |
| Nov 15, 2021 | Jacobs Jeffrey W | Chief Scientific Officer | Form 4 sale | 5,000 | $6k | 3.8% | Plan not stated | SEC |
| Nov 12, 2021 | Grammer Elizabeth A | Officer | Form 4 sale | 77,432 | $87k | 21.9% | Unusual | SEC |
| Nov 8, 2021 | Jacobs Jeffrey W | Chief Scientific Officer | Form 4 sale | 2,166 | $3k | 1.6% | Plan not stated | SEC |
| Aug 20, 2021 | Rosenbaum David P. | Chief Development Officer | Form 4 sale | 807 | $1k | 0.5% | Plan not stated | SEC |
| Aug 20, 2021 | Rodriguez Susan | Chief Commercial Officer | Form 4 sale | 630 | $832 | 1.4% | Plan not stated | SEC |
| Aug 20, 2021 | Renz Justin A | Chief Financial Officer | Form 4 sale | 631 | $833 | 1.6% | Plan not stated | SEC |
| Aug 20, 2021 | Raab Michael | President & CEO | Form 4 sale | 2,573 | $3k | 0.8% | Plan not stated | SEC |
| Aug 20, 2021 | Jacobs Jeffrey W | Chief Scientific Officer | Form 4 sale | 741 | $978 | 0.6% | Plan not stated | SEC |
| Aug 20, 2021 | Grammer Elizabeth A | Officer | Form 4 sale | 526 | $694 | 0.5% | Plan not stated | SEC |
| Aug 20, 2021 | Blanks Robert | Officer | Form 4 sale | 631 | $833 | 0.6% | Plan not stated | SEC |
| Jun 15, 2021 | Jacobs Jeffrey W | Chief Scientific Officer | Form 4 sale | 7,500 | $55k | 5.7% | Unusual | SEC |
| May 28, 2021 | Rosenbaum David P. | Chief Development Officer | Form 4 sale | 3,062 | $22k | 10.3% | Plan not stated | SEC |
| May 20, 2021 | Rosenbaum David P. | Chief Development Officer | Form 4 sale | 769 | $5k | 0.5% | Plan not stated | SEC |
| May 20, 2021 | Rodriguez Susan | Chief Commercial Officer | Form 4 sale | 611 | $4k | 1.3% | Plan not stated | SEC |
| May 20, 2021 | Renz Justin A | Chief Financial Officer | Form 4 sale | 612 | $4k | 1.5% | Plan not stated | SEC |
| May 20, 2021 | Raab Michael | President & CEO | Form 4 sale | 2,534 | $18k | 1.2% | Plan not stated | SEC |
| May 20, 2021 | Jacobs Jeffrey W | Chief Scientific Officer | Form 4 sale | 721 | $5k | 0.6% | Plan not stated | SEC |
| May 20, 2021 | Grammer Elizabeth A | Officer | Form 4 sale | 508 | $4k | 0.5% | Plan not stated | SEC |
| May 20, 2021 | Blanks Robert | Officer | Form 4 sale | 612 | $4k | 0.6% | Plan not stated | SEC |
| Apr 6, 2021 | Rosenbaum David P. | Chief Development Officer | Form 4 sale | 5,000 | $40k | 3.0% | Plan not stated | SEC |
| Apr 6, 2021 | Blanks Robert | Officer | Form 4 sale | 5,163 | $41k | 4.6% | Plan not stated | SEC |
| Feb 22, 2021 | Blanks Robert | Officer | Form 4 sale | 593 | $4k | 0.5% | Plan not stated | SEC |
| Feb 22, 2021 | Jacobs Jeffrey W | Chief Scientific Officer | Form 4 sale | 702 | $5k | 0.6% | Plan not stated | SEC |
| Feb 22, 2021 | Rodriguez Susan | Chief Commercial Officer | Form 4 sale | 611 | $4k | 1.3% | Plan not stated | SEC |
| Feb 22, 2021 | Raab Michael | President & CEO | Form 4 sale | 2,534 | $17k | 1.2% | Plan not stated | SEC |
| Feb 22, 2021 | Rosenbaum David P. | Chief Development Officer | Form 4 sale | 805 | $6k | 0.5% | Plan not stated | SEC |
| Feb 22, 2021 | Renz Justin A | Chief Financial Officer | Form 4 sale | 608 | $4k | 1.5% | Plan not stated | SEC |
| Feb 22, 2021 | Grammer Elizabeth A | Officer | Form 4 sale | 504 | $3k | 0.5% | Plan not stated | SEC |
| Dec 21, 2020 | Jacobs Jeffrey W | Chief Scientific Officer | Form 4 sale | 3,949 | $27k | 4.1% | Plan not stated | SEC |
| Dec 14, 2020 | Grammer Elizabeth A | Officer | Form 4 sale | 42,000 | $307k | 36.7% | Unusual | SEC |
| Sep 16, 2020 | Rodriguez Susan | Chief Commercial Officer | Form 4 sale | 6,087 | $37k | 30.4% | Unusual | SEC |
| Sep 16, 2020 | Jacobs Jeffrey W | SVP, Technical Operations | Form 4 sale | 50,804 | $286k | 34.4% | Unusual | SEC |
| Sep 15, 2020 | Rosenbaum David P. | Chief Development Officer | Form 4 sale | 38,126 | $210k | 22.3% | Unusual | SEC |
| Sep 15, 2020 | Blanks Robert | Officer | Form 4 sale | 34,685 | $189k | 30.1% | Unusual | SEC |
| Sep 15, 2020 | Renz Justin A | Chief Financial Officer | Form 4 sale | 3,714 | $20k | 28.6% | Unusual | SEC |
| Sep 15, 2020 | Raab Michael | President & CEO | Form 4 sale | 106,337 | $597k | 50.4% | Unusual | SEC |
| Sep 15, 2020 | Grammer Elizabeth A | Officer | Form 4 sale | 28,810 | $155k | 28.4% | Unusual | SEC |
| Sep 1, 2020 | Blanks Robert | Officer | Form 4 sale | 2,049 | $11k | 1.7% | Plan not stated | SEC |
| Jul 2, 2020 | Raab Michael | President & CEO | Form 4 sale | 23,128 | $162k | 48.7% | Unusual | SEC |
| Jun 15, 2020 | Sandell Scott D | 10% owner | Form 4 sale | 43 | $274 | 100.0% | Unusual | SEC |
| Jun 15, 2020 | Baskett Forest | 10% owner | Form 4 sale | 43 | $274 | 100.0% | Unusual | SEC |
| Jun 12, 2020 | Sandell Scott D | 10% owner | Form 4 sale | 89,983 | $573k | 100.0% | Unusual | SEC |
| Jun 12, 2020 | Baskett Forest | 10% owner | Form 4 sale | 112,883 | $719k | 100.0% | Unusual | SEC |
| Jun 1, 2020 | Raab Michael | President & CEO | Form 4 sale | 23,128 | $170k | 33.3% | Unusual | SEC |
| May 5, 2020 | Raab Michael | President & CEO | Form 4 sale | 20,427 | $143k | 22.7% | Plan not stated | SEC |
| Apr 27, 2020 | Grammer Elizabeth A | Officer | Form 4 sale | 17,824 | $133k | 14.9% | Unusual | SEC |
| Apr 17, 2020 | Raab Michael | President & CEO | Form 4 sale | 20,428 | $143k | 18.5% | Plan not stated | SEC |
| Mar 2, 2020 | Raab Michael | President & CEO | Form 4 sale | 31,551 | $221k | 13.2% | Plan not stated | SEC |
| Feb 5, 2020 | Raab Michael | President & CEO | Form 4 sale | 25,000 | $183k | 10.8% | Plan not stated | SEC |
| Dec 3, 2019 | Grammer Elizabeth A | EVP, General Counsel | Form 4 sale | 5,000 | $40k | 4.1% | Plan not stated | SEC |
| Nov 19, 2019 | Grammer Elizabeth A | EVP, General Counsel | Form 4 sale | 5,000 | $35k | 4.1% | Plan not stated | SEC |
| Oct 7, 2019 | Kaufmann Mark | Chief Financial Officer | Form 4 sale | 20,000 | $91k | 12.4% | Unusual | SEC |
| Aug 22, 2019 | Grammer Elizabeth A | EVP, General Counsel | Form 4 sale | 5,000 | $18k | 4.1% | Plan not stated | SEC |
| Aug 19, 2019 | Grammer Elizabeth A | EVP, General Counsel | Form 4 sale | 5,874 | 4.6% | Plan not stated | SEC | |
| Jun 4, 2019 | Rosenbaum David P. | Chief Development Officer | Form 4 sale | 2,856 | $7k | 1.8% | Plan not stated | SEC |
| Jun 4, 2019 | Raab Michael | President & CEO | Form 4 sale | 10,054 | $26k | 3.8% | Plan not stated | SEC |
| Jun 4, 2019 | Kaufmann Mark | Chief Financial Officer | Form 4 sale | 3,357 | $9k | 2.4% | Plan not stated | SEC |
| Jun 4, 2019 | Grammer Elizabeth A | SVP, General Counsel | Form 4 sale | 2,520 | $6k | 1.9% | Plan not stated | SEC |
| Jan 2, 2019 | Rosenbaum David P. | Chief Development Officer | Form 4 sale | 6,386 | $11k | 3.8% | Unusual | SEC |
| Jan 2, 2019 | Raab Michael | President & CEO | Form 4 sale | 19,644 | $33k | 7.0% | Plan not stated | SEC |
| Jan 2, 2019 | Kaufmann Mark | Chief Financial Officer | Form 4 sale | 6,556 | $11k | 4.5% | Plan not stated | SEC |
| Jan 2, 2019 | Grammer Elizabeth A | EVP, General Counsel | Form 4 sale | 4,920 | $8k | 3.7% | Plan not stated | SEC |
| Nov 13, 2018 | Grammer Elizabeth A | EVP, General Counsel | Form 4 sale | 6,539 | $19k | 4.6% | Plan not stated | SEC |
| Nov 13, 2018 | Raab Michael | President & CEO | Form 4 sale | 6,539 | $19k | 2.2% | Plan not stated | SEC |
| Nov 13, 2018 | Kaufmann Mark | Chief Financial Officer | Form 4 sale | 6,539 | $19k | 4.3% | Plan not stated | SEC |
| Nov 13, 2018 | Rosenbaum David P. | Chief Development Officer | Form 4 sale | 5,570 | $16k | 3.3% | Unusual | SEC |
| Nov 12, 2018 | Sandell Scott D | 10% owner | Form 4 sale | 592 | $2k | 100.0% | Unusual | SEC |
| Oct 24, 2017 | Seeto Reginald | Chief Operating Officer | Form 4 sale | 10,008 | $52k | 6.3% | Plan not stated | SEC |
| Aug 30, 2017 | Baskett Forest | 10% owner | Form 4 sale | 485 | $2k | 100.0% | Unusual | SEC |
| Apr 18, 2017 | Rosenbaum David P. | Chief Development Officer | Form 4 sale | 2,051 | $25k | 4.9% | Plan not stated | SEC |
| Mar 10, 2017 | Rosenbaum David P. | SVP, Drug Development | Form 4 sale | 1,000 | $13k | 43.9% | Unusual | SEC |
| Mar 3, 2017 | Caldwell Jeremy S | EVP, Chief Scientific Officer | Form 4 sale | 1,026 | $15k | 5.4% | Plan not stated | SEC |
| Mar 1, 2017 | Jacobs Jeffrey W | SVP, Technical Operations | Form 4 sale | 3,000 | $41k | 4.2% | Plan not stated | SEC |
| Feb 1, 2017 | Jacobs Jeffrey W | SVP, Technical Operations | Form 4 sale | 3,000 | $36k | 4.3% | Plan not stated | SEC |
| Jan 5, 2017 | Korner Paul | EVP, Chief Medical Officer | Form 4 sale | 6,130 | $79k | 10.1% | Plan not stated | SEC |
| Dec 16, 2016 | Rosenbaum David P. | SVP, Drug Development | Form 4 sale | 900 | $13k | 58.6% | Unusual | SEC |
| Nov 11, 2016 | Caldwell Jeremy S | EVP, Chief Scientific Officer | Form 4 sale | 2,158 | $33k | 100.0% | Unusual | SEC |
| Oct 11, 2016 | Jacobs Jeffrey W | SVP, Technical Operations | Form 4 sale | 6,000 | $90k | 10.8% | Unusual | SEC |
| Sep 23, 2016 | Grammer Elizabeth A | SVP, General Counsel | Form 4 sale | 5,000 | $60k | 100.0% | Unusual | SEC |
| Sep 19, 2016 | Grammer Elizabeth A | SVP, General Counsel | Form 4 sale | 6,859 | $77k | 100.0% | Unusual | SEC |
| Mar 3, 2016 | Rosenbaum David P. | SVP, Drug Development | Form 4 sale | 1,128 | $12k | 4.8% | Plan not stated | SEC |
| Feb 16, 2016 | Kaufmann Mark | Chief Financial Officer | Form 4 sale | 5,000 | $51k | 79.6% | Unusual | SEC |
| Dec 15, 2015 | Jacobs Jeffrey W | SVP, Technical Operations | Form 4 sale | 2,000 | $40k | 4.0% | Plan not stated | SEC |
| Nov 27, 2015 | Jacobs Jeffrey W | SVP, Technical Operations | Form 4 sale | 2,000 | $40k | 4.0% | Plan not stated | SEC |
| Oct 8, 2015 | Jacobs Jeffrey W | SVP, Technical Operations | Form 4 sale | 2,000 | $40k | 4.0% | Plan not stated | SEC |
| Sep 22, 2015 | Rosenbaum David P. | SVP, Drug Development | Form 4 sale | 1,400 | $31k | 1.9% | Plan not stated | SEC |
| Sep 15, 2015 | Rosenbaum David P. | SVP, Drug Development | Form 4 sale | 2,540 | $56k | 3.3% | Plan not stated | SEC |
| Sep 10, 2015 | Jacobs Jeffrey W | SVP, Technical Operations | Form 4 sale | 2,000 | $41k | 4.0% | Plan not stated | SEC |
| Sep 8, 2015 | Raab Michael | President & CEO | Form 4 sale | 9,785 | $199k | 12.2% | Unusual | SEC |
| Sep 3, 2015 | Rosenbaum David P. | SVP, Drug Development | Form 4 sale | 2,537 | $48k | 100.0% | Unusual | SEC |
| Sep 1, 2015 | Caldwell Jeremy S | EVP, Chief Scientific Officer | Form 4 sale | 643 | $12k | 100.0% | Unusual | SEC |
| Sep 1, 2015 | Grammer Elizabeth A | VP, General Counsel | Form 4 sale | 893 | $16k | 100.0% | Unusual | SEC |
| Aug 18, 2015 | Raab Michael | President & CEO | Form 4 sale | 1,104 | $22k | 1.4% | Plan not stated | SEC |
| Aug 6, 2015 | Jacobs Jeffrey W | SVP, Technical Operations | Form 4 sale | 2,000 | $38k | 4.1% | Plan not stated | SEC |
| Aug 3, 2015 | Raab Michael | President & CEO | Form 4 sale | 300 | $6k | 0.4% | Plan not stated | SEC |
| Jul 30, 2015 | Rosenbaum David P. | SVP, Drug Development | Form 4 sale | 2,011 | $39k | 2.6% | Plan not stated | SEC |
| Jul 28, 2015 | Raab Michael | President & CEO | Form 4 sale | 2,111 | $42k | 2.5% | Plan not stated | SEC |
| Jul 22, 2015 | Grammer Elizabeth A | VP, General Counsel | Form 4 sale | 2,500 | $45k | 100.0% | Unusual | SEC |
| Jul 15, 2015 | Grammer Elizabeth A | VP, General Counsel | Form 4 sale | 10,000 | $171k | 100.0% | Unusual | SEC |
| May 4, 2015 | Kaufmann Mark | Chief Financial Officer | Form 4 sale | 9,083 | $98k | 93.8% | Unusual | SEC |
| Apr 6, 2015 | Kaufmann Mark | Chief Financial Officer | Form 4 sale | 7,681 | $98k | 92.8% | Unusual | SEC |
| Mar 3, 2015 | Kaufmann Mark | Chief Financial Officer | Form 4 sale | 6,075 | $95k | 91.1% | Unusual | SEC |
| Mar 2, 2015 | Grammer Elizabeth A | VP, General Counsel | Form 4 sale | 1,737 | $27k | 25.8% | Unusual | SEC |
| Mar 2, 2015 | Jacobs Jeffrey W | VP, Chemistry | Form 4 sale | 981 | $16k | 2.1% | Plan not stated | SEC |
| Mar 2, 2015 | Jue George | VP, Operations | Form 4 sale | 1,500 | $24k | 5.9% | Plan not stated | SEC |
| Feb 4, 2015 | Jacobs Jeffrey W | VP, Chemistry | Form 4 sale | 8,888 | $145k | 16.0% | Plan not stated | SEC |
| Jan 30, 2015 | Cmea Ventures Vii (parallel) LP | 10% owner | Form 4 sale | 170,000 | $4.7M | 5.1% | Plan not stated | SEC |
| Jan 8, 2015 | Cmea Ventures Vii (parallel) LP | 10% owner | Form 4 sale | 300,000 | $7.3M | 8.3% | Plan not stated | SEC |
| Dec 29, 2014 | Kolluri Krishna Kittu | 10% owner | Form 4 sale | 267 | $5k | 100.0% | Unusual | SEC |
| Dec 26, 2014 | Barris Peter J | 10% owner | Form 4 sale | 1,972 | $42k | 100.0% | Unusual | SEC |
| Dec 26, 2014 | Barrett M James | 10% owner | Form 4 sale | 2,564 | $55k | 100.0% | Unusual | SEC |
| Dec 26, 2014 | Baskett Forest | 10% owner | Form 4 sale | 1,972 | $42k | 100.0% | Unusual | SEC |
| Dec 26, 2014 | Sandell Scott D | 10% owner | Form 4 sale | 1,972 | $42k | 100.0% | Unusual | SEC |